Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Atle Fund Management AB
Form 13F · Q2 2026

Atle Fund Management AB

CIK 1381843Filed 2026-07-2413F-HR View the filing on EDGAR ↗
$372M
Reported book value
39
Positions
11
Quarters on record
Top 50
Positions

Atle Fund Management AB — holdings

Top 39 positions of 39, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1LLY Eli Lilly & Co29,821−24.9%$36M9.6%
2MRK Merck & Co Inc189,357+459.4%$24M6.5%
3JNJ Johnson & Johnson85,425−7.5%$22M5.8%
4ABBV Abbvie Inc64,325−40.5%$16M4.4%
5CVS Cvs Health Corp146,102+514.6%$15M4.1%
6TMO Thermo Fisher Scientific Inc27,859+21.2%$14M3.8%
7RVMD Revolution Medicines Inc73,077−88.2%$14M3.7%
8BIIB Biogen Inc62,781—$14M3.6%
9NBIX Neurocrine Biosciences Inc72,898−18.7%$12M3.3%
10MIRM Mirum Pharmaceuticals Inc100,807−48.5%$12M3.2%
11ALKS Alkermes Plc213,329−12.0%$11M3.0%
12IONS Ionis Pharmaceuticals Inc137,131+392.0%$11M2.9%
13ONC Beone Medicines Ltd35,180−15.7%$10M2.7%
14ISRG Intuitive Surgical Inc24,656−65.2%$10M2.6%
15SYK Stryker Corporation30,283+12.8%$10M2.6%
16VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc19,131−16.8%$10M2.6%
17EW Edwards Lifesciences Corp103,230−3.1%$9M2.5%
18BBIO Bridgebio Pharma Inc124,707+12.0%$9M2.5%
19KRYS Krystal Biotech Inc24,019−36.1%$9M2.4%
20COR Cencora Inc31,126+32.6%$9M2.4%
21NAMS Newamsterdam Pharma Company248,848+162.5%$8M2.3%
22ABIVAX SA Abivax Sa58,170+84.1%$8M2.1%
23INCY Incyte Corp56,953+12.1%$6M1.7%
24IRTC Irhythm Holdings Inc54,102+142.4%$6M1.7%
25BSX Boston Scientific Corp146,381+262.0%$6M1.7%
26INSM Insmed Inc58,378−40.1%$6M1.7%
27TNGX Tango Therapeutics Inc198,557+563.7%$6M1.7%
28GILD Gilead Sciences Inc46,142−3.8%$6M1.6%
29CAH Cardinal Health Inc23,630−78.3%$6M1.5%
30ORKA Oruka Therapeutics Inc54,886—$5M1.4%
31SYRE Spyre Therapeutics Inc57,030−9.1%$5M1.4%
32DXCM Dexcom Inc71,846−87.7%$5M1.3%
33BCAX Bicara Therapeutics Inc145,657−87.5%$4M1.2%
34IDYA Ideaya Biosciences Inc94,478+203.5%$4M0.9%
35CELC Celcuity Inc33,313−76.4%$3M0.9%
36IRON Disc Medicine Inc43,682−59.3%$3M0.9%
37PYXS Pyxis Oncology Inc966,459+390.5%$3M0.8%
38CMPX Compass Therapeutics Inc1.0M+2406.7%$2M0.6%
39JBIO Jade Biosciences Inc88,556—$2M0.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.